Ziopharm Oncology is focused on advancing the next generation of immunotherapies to weaponize the existing immune system with Controlled IL-12 or introduce new immune system elements with Sleeping Beauty-modified T cells to this fight against cancer. In addition to developing the next generation of immuno-oncology medicines that target multiple types of cancers, we also are targeting the cost and complexity of delivering gene and cell therapies.
Events & Presentations
Mar 2, 2020 4:30 PM EST
Ziopharm Fourth Quarter 2019 Earnings Call
Jan 16, 2020 1:00 PM EST
Ziopharm Oncology 38th Annual J.P. Morgan Healthcare Conference - Q&A
Jan 16, 2020 12:30 PM EST
Ziopharm Oncology at 38th Annual J.P. Morgan Healthcare Conference - Presentation